Time is Brain: Early AD Patient
Identification and Diagnosis

As our understanding of Alzheimer’s disease (AD) evolves, strategies to diagnose and manage this disease are changing from a ‘wait and see’ approach to focus on early diagnosis and best practices in patient identification. The following resources are available to view, download, or listen. These materials are intended for healthcare professionals seeking to understand AD staging, referral pathways, and clinical assessments used to evaluate cognitive and functional impairment.

As our understanding of Alzheimer’s disease (AD) evolves, strategies to diagnose and manage this disease are changing from a ‘wait and see’ approach to focus on early diagnosis and best practices in patient identification. The following resources are available to view, download, or listen. These materials are intended for healthcare professionals seeking to understand AD staging, referral pathways, and clinical assessments used to evaluate cognitive and functional impairment.

    Sort By

    Resources

    Content Type


    Apply Clear

Unfortunately, there are no results for this topic. Please modify your search.

Click Here to Go back

{{ promo.Title.slice(0, 160) }} Tooltip

{{ promo.Title }}

Title of the activity : {{ promo.Title }}

Provider : {{ promo.Provider }}

Virtual Enduring : {{ promo.VirtualEnduring }}

{{ promo.Title.slice(0, 160) }}

{{ promo.Title}}

{{ truncateText(promo.Title, promo.Description, 160) }}

Tooltip

{{ promo.Title }}

{{ promo.Description }}

{{ promo.AssetTag }}

COMING SOON

{{ promo.CTAText }}
Load More

Clinical Trials

Notepad

Clinical Trials

Eisai has numerous drug candidates in clinical development and is actively recruiting for trials in neurology.

Explore Clinical Trials

Grants

Support

Grants

This website provides policies and procedures for the preparation and submission of requests for Medical Education Grants (ME) and Investigator-Initiated Studies (IIS).

Explore Eisai Grants Process